Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Pharmacokinetics and metabolism of mitoxantrone. A review.
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Microglia in health and disease.
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
Masitinib in Patients with Primary Progressive Multiple Sclerosis (PPMS) or Relapse-Free Secondary Multiple Sclerosis (SPMS)
“Human Medicines” page
The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk.
Breastfeeding and multiple sclerosis relapses: a meta-analysis.
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study.
Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets Diverse Needs of Patients
Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange.
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Multiple sclerosis: pathogenesis and treatment.

Pages